164 related articles for article (PubMed ID: 36168087)
21. Establishing a cancer driver gene signature-based risk model for predicting the prognoses of gastric cancer patients.
Chen J; Zhou C; Liu Y
Aging (Albany NY); 2022 Mar; 14(5):2383-2399. PubMed ID: 35288483
[TBL] [Abstract][Full Text] [Related]
22. Identification of immune infiltration-related genes as prognostic indicators for hepatocellular carcinoma.
Dai K; Liu C; Guan G; Cai J; Wu L
BMC Cancer; 2022 May; 22(1):496. PubMed ID: 35513781
[TBL] [Abstract][Full Text] [Related]
23. Identification of a novel 10 immune-related genes signature as a prognostic biomarker panel for gastric cancer.
Chen T; Yang C; Dou R; Xiong B
Cancer Med; 2021 Sep; 10(18):6546-6560. PubMed ID: 34382341
[TBL] [Abstract][Full Text] [Related]
24. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
25. Construction and validation of a bladder cancer risk model based on autophagy-related genes.
Shen C; Yan Y; Yang S; Wang Z; Wu Z; Li Z; Zhang Z; Lin Y; Li P; Hu H
Funct Integr Genomics; 2023 Jan; 23(1):46. PubMed ID: 36689018
[TBL] [Abstract][Full Text] [Related]
26.
Yang Y; Chen Z; Zhou L; Wu G; Ma X; Zheng Y; Liu M; Wang Y; Ji R; Guo Q; Zhou Y
Transl Cancer Res; 2022 Jul; 11(7):1977-1993. PubMed ID: 35966316
[TBL] [Abstract][Full Text] [Related]
27. Development of a Prognostic Model for Gastric Cancer Based on Apoptosis- and Hypoxia-Related Genes: Predictive Insights into Survival and Immune Landscape.
Zhu J; Ma Y
J Environ Pathol Toxicol Oncol; 2024; 43(3):81-93. PubMed ID: 38608147
[TBL] [Abstract][Full Text] [Related]
28. Gastric Cancer Immune Subtypes and Prognostic Modeling: Insights from Aging-Related Gene Analysis.
Shen J; Li M
Crit Rev Immunol; 2024; 44(5):1-13. PubMed ID: 38618724
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer.
Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C
Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494
[TBL] [Abstract][Full Text] [Related]
30. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
[No Abstract] [Full Text] [Related]
31. The prognostic role of fatty acid metabolism-related genes in patients with gastric cancer.
Xu W; Ding H; Zhang M; Liu L; Yin M; Weng Z; Xu C
Transl Cancer Res; 2022 Oct; 11(10):3593-3609. PubMed ID: 36388036
[TBL] [Abstract][Full Text] [Related]
32. A vasculogenic mimicry prognostic signature associated with immune signature in human gastric cancer.
Wang J; Xia W; Huang Y; Li H; Tang Y; Li Y; Yi B; Zhang Z; Yang J; Cao Z; Zhou J
Front Immunol; 2022; 13():1016612. PubMed ID: 36505458
[TBL] [Abstract][Full Text] [Related]
33. Identification and verification of a glycolysis-related gene signature for gastric cancer.
Liu Y; Wu M; Cao J; Zhu Y; Ma Y; Pu Y; Huo X; Wang J
Ann Transl Med; 2022 Sep; 10(18):1010. PubMed ID: 36267782
[TBL] [Abstract][Full Text] [Related]
34. The predictive effect of immune therapy and chemotherapy under T cell-related gene prognostic index for Gastric cancer.
Chen J; Li X; Mak TK; Wang X; Ren H; Wang K; Kuo ZC; Wu W; Li M; Hao T; Zhang C; He Y
Front Cell Dev Biol; 2023; 11():1161778. PubMed ID: 37274740
[No Abstract] [Full Text] [Related]
35. Integrative analysis-based identification and validation of a prognostic immune cell infiltration-based model for patients with advanced gastric cancer.
Pan S; Gao Q; Chen Q; Liu P; Tan Y; Liu F; Xu H
Int Immunopharmacol; 2021 Dec; 101(Pt B):108258. PubMed ID: 34678693
[TBL] [Abstract][Full Text] [Related]
36. A signature of seven immune-related genes predicts overall survival in male gastric cancer patients.
Xu X; Lu Y; Wu Y; Wang M; Wang X; Wang H; Chen B; Li Y
Cancer Cell Int; 2021 Feb; 21(1):117. PubMed ID: 33602220
[TBL] [Abstract][Full Text] [Related]
37. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
38. Identification of a new RNA-binding proteins-based signature for prognostic prediction in gastric cancer.
Wang Y; Ye W; Tian G; Zhang Y
Medicine (Baltimore); 2022 Feb; 101(8):e28901. PubMed ID: 35212295
[TBL] [Abstract][Full Text] [Related]
39. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
40. A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer.
Liu SJ; Yang YB; Zhou JX; Lin YJ; Pan YL; Pan JH
Dis Markers; 2021; 2021():2385406. PubMed ID: 34868391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
